News

September 15, 2017

Lymphoma patient’s ‘lucky colors’ to boost Kasey Kahne at NASCAR

When NASCAR drivers hit the Chicagoland Speedway, Enumclaw's Kasey Kahne will have a little extra luck on his side. Wyatt Zender, an outgoing, outdoorsy 9-year old, was diagnosed with Hodgkin lymphoma at Seattle Children’s.
September 6, 2017

FDA approves the first immunotherapy drug for childhood leukemia

The FDA approved a new drug therapy for pediatric leukemia that uses immunotherapy, or the re-engineering of a person’s own T cells to enable them to fight cancer.
August 11, 2017

Seattle Children’s Aims to Outsmart Cancer in a New Trial

Seattle Children's Ben Towne Center for Childhood Cancer Research is actively fighting pediatric leukemia by harvesting and reprogramming a child's own T cells and using the immune system to fight cancer.
July 27, 2017

Seattle Children’s Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia Escapes CD19 CAR T-Cell Therapy

With 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission in their PLAT-02 trial, researchers at Seattle Children’s are continuing to improve the experimental immunotherapy and reduce the rate of relapse.